Product Overview
Tesamorelin 10mg is a pharmaceutical-grade, high-ppurity synthetic peptide designed for advanced scientific research. As a potent Growth Hormone-Releasing Hormone (GHRH) analog, Tesamorelin features a meticulously engineered 44-amino acid structure with a modified N-terminus, significantly enhancing its stability and biological efficacy compared to endogenous GHRH.
This lyophilized peptide is extensively studied for its precise ability to stimulate endogenous growth hormone (GH) production, making it an invaluable tool for metabolic, endocrine, and body composition research. Supplied in a 10mg vial, it requires reconstitution with bacteriostatic water for accurate in vitro laboratory applications.
Primary Research Applications
Tesamorelin is a pivotal compound in studies investigating complex metabolic and endocrine functions:
- Lipodystrophy Research: A leading focus for reducing visceral adipose tissue (VAT) in models of abnormal fat distribution.
- Metabolic Health & Body Composition: Exploring its role in modulating lipid metabolism and improving overall body composition metrics.
- Cognitive Function & Aging Models: Investigating potential effects on neural health and cognitive performance in age-related research.
- Cardiovascular Biomarkers: Analyzing impacts on metabolic parameters and markers associated with cardiovascular risk.
- Endocrine System Studies: Comprehensive examination of GH and IGF-1 regulation within various research models.
Understanding Tesamorelin: GHRH Analog Mechanism of Action
Tesamorelin's unique efficacy stems from its selective and sustained activation of pituitary somatotroph cells. This mechanism ensures the synthesis and release of endogenous growth hormone (GH) in a physiologically pulsatile manner, preserving natural regulatory feedback loops.
Key Research Pathways:
- Selective Pituitary Stimulation: Binds specifically to GHRH receptors on somatotroph cells.
- GH Secretion Dynamics: Triggers a cascade involving adenylate cyclase and increased cyclic AMP (cAMP), leading to robust GH release.
- IGF-1 Pathway Activation: Elevated GH levels subsequently increase insulin-like growth factor-1 (IGF-1), a key mediator of growth and metabolic effects.
- Enhanced Stability: Its modified structure, including a trans-3-hexenoyl group, significantly improves binding affinity and resistance to enzymatic degradation, ensuring prolonged activity in research models.
Storage & Handling Guidelines
To maintain the integrity and potency of your Tesamorelin peptide:
- Long-term Storage (Lyophilized): Store unopened vials at -20°C or below.
- Short-term Storage: Refrigerate at 2°C–8°C for immediate research use.
- Reconstitution: Reconstitute with bacteriostatic water. Once reconstituted, store at 2°C–8°C and use within 21-28 days.
- Protection: Keep vials protected from light, heat, and moisture.
Reviews
There are no reviews yet.